Ann: Application for quotation of securities - CAN, page-14

I seem to recall CAN put alot of faith (and money) into a clinical trial which if it had been successful would have seen CAN have a monopoly over the market.

I'm still yet to hear of any other companies attempting it. So could this have contributed to challenges they now face? Please don't tell me you are still stuck thinking that CAN only spent money on a greenhouse? Mind you this would suit your narrative of indoor vs outdoor...

Do you have any examples of other companies commencing greenhouse builds then aborting because of the signals from the Canadian market? How are they faring now? Are they trading at all time lows along side ECS?

I note you ignored my question earlier and chose to deflect with more questions for me. How rude.